RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $355,000 | -14.7% | 14,550 | -7.3% | 0.01% | -14.3% |
| Q1 2021 | $416,000 | +127.3% | 15,700 | -35.0% | 0.01% | +133.3% |
| Q4 2020 | $183,000 | +10.2% | 24,143 | -27.3% | 0.00% | -40.0% |
| Q3 2020 | $166,000 | +29.7% | 33,200 | +55.1% | 0.01% | -16.7% |
| Q2 2020 | $128,000 | – | 21,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |